Grant: CIHR Fellowship
Direct Payment
$129,167.00
The role of fibroblast growth factor 2 in hypothalamic-pituitary adrenal axis responsivity and anxiety behavior
EF 2011-12
Résumé
Amongst all categories of mental illness, anxiety disorders have the highest prevalence rate in Canada. However, despite the alarmingly high incidence of these disorders, little is known about the neurobiological underpinnings of these disorders. Recent work both from our laboratory and others has implicated a role for fibroblast growth factor 2 in anxiety disorders. In my early post-doctoral work, I have shown that removing the function of the fibroblast growth factor gene in mice results in a severe anxiety behavior phenotype, associated with dysregulation of the hypothalamic pituitary adrenal axis, the major endocrine system which regulates cortisol in humans and corticosterone in rodents: hormones involved in the stress response. The current proposed studies would 1) try to ascertain if this is largely a developmental effect, or whether acute administration of fibroblast growth factor 2 would reverse the anxiety phenotype; and 2) what are the downstream mechanisms through which fibroblast growth factor 2 exerts its effects on the hypothalamic pituitary adrenal axis by use of gene expression studies.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Connecticut, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
242632
Name
Salmaso Natalina
Region
Connecticut
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The role of fibroblast growth factor 2 in hypothalamic-pituitary adrenal axis responsivity and anxiety behavior
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$129,167
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Anxiety; Development; Epigenetics; Fgf2; Glucocorticoid; Hippocampus; Hypothalamus-Pituitary-Adrenal Axis; Mice
Abstract
Amongst all categories of mental illness, anxiety disorders have the highest prevalence rate in Canada. However, despite the alarmingly high incidence of these disorders, little is known about the neurobiological underpinnings of these disorders. Recent work both from our laboratory and others has implicated a role for fibroblast growth factor 2 in anxiety disorders. In my early post-doctoral work, I have shown that removing the function of the fibroblast growth factor gene in mice results in a severe anxiety behavior phenotype, associated with dysregulation of the hypothalamic pituitary adrenal axis, the major endocrine system which regulates cortisol in humans and corticosterone in rodents: hormones involved in the stress response. The current proposed studies would 1) try to ascertain if this is largely a developmental effect, or whether acute administration of fibroblast growth factor 2 would reverse the anxiety phenotype; and 2) what are the downstream mechanisms through which fibroblast growth factor 2 exerts its effects on the hypothalamic pituitary adrenal axis by use of gene expression studies.
Competitiondate
201110
Approvedterm2
2 yrs 7 mths
Pinamesdelim
Salmaso, Natalina
Approvedterm
2 ans 7 mois
Cihrcontribution2
~ $129,167~ $0~